AZ ASTHMA COALITION MOA_STOCKMEDS.PDF

Page 1 
MEMORANDUM OF AGREEMENT  
between 
MARICOPA COUNTY 
DEPARTMENT OF PUBLIC HEALTH 
AND 
ARIZONA ASTHMA COALITION 
This is an agreement between Maricopa County by and through the Department of Public Health 
(MCDPH) and Arizona Asthma Coalition (AAC).  
Term of this agreement: 
July 1, 2020 through June 30, 2023 
Agreement Amount: 
$17,000 to be paid in one (1) lump-sum installment 
I. 
PURPOSE & SCOPE 
AAC agrees to compensate MCDPH for the purpose of providing school stock albuterol 
inhalers and LiteAire® spacers to schools who meet the MCDPH School Surveillance 
Medication Program (SSMP) eligibility criteria: 
•
At least two school staff who have completed the annual training on recognition of
respiratory distress, administration of albuterol and safely store medication.
•
Data collection from prior school year (see Exhibit A)
•
School District/ Organization approval to implement the program
II.
BACKGROUND
Arizona HB 2208 and related Arizona State Board of Education regulation pursuant to 
ARS § 15-158, now make it possible for public, charter, and private schools to administer 
emergency albuterol inhalers if a student or adult experiences respiratory distress. 
Asthma prevalence among children is about 10%.  In Arizona, severe respiratory distress 
among children leads to lost school time and approximately 2,700 9-1-1 calls every 
year. About 50% of these calls result in EMS transports to the emergency department. 
This MOA is an opportunity to provide schools with immediate and medically 
appropriate relief to any student, staff or visitor who experiences respiratory distress. It 
will additionally reduce 911 calls and transports to the emergency room, allow most 
children to return to class after treatment for an episode, thus reducing lost school time, 
reduce lost work time for parent and identifies children who need to be evaluated by a 
physician or provider for respiratory care.   
III.
MCDPH RESPONSIBILITITES UNDER THIS MOA.
•
Provide the purchase of an albuterol inhaler and LiteAire® spacers to schools who
meet the MCDPH School Surveillance Medication Program (SSMP) requirements in

Page 2 
accordance with R7-2-810 Emergency Administration of Inhalers and pursuant to 
ARS § 15-158.  
 
 
IV. 
AAC RESPONSIBILITITES UNDER THIS MOA  
 
• Grant permission to MCDPH to purchase school stock albuterol inhaler and LiteAire 
spacers to schools who meet the SSMP requirements 
• Fund SSMP as agreed per VI. Compensation below 
 
V. 
INDEMNITY: 
 
MCDPH is a Self-Insured government entity.  
 
Each party (as "Indemnitor"), to the fullest extent permitted by law, agrees to indemnify, 
defend, and hold harmless the other party (as "Indemnitee") from and against any and all 
claims, losses, liability, costs, or expenses (including reasonable attorney's fees) (hereinafter 
collectively referred to as "claims") arising out of the negligent performance of this agreement, 
but only to the extent that such claims which result in vicarious/derivative liability to the 
Indemnitee are caused by the act, omission, negligence, misconduct, or other fault of the 
Indemnitor, its officers, officials, agents, employees, or volunteers.   
 
VI. 
COMPENSATION 
 
a. AAC agrees to a one-time indirect cost reimbursement to MCDPH of 10%. 
 
b. AAC will compensate MCDPH for according to the following schedule: 
 
1. $17,000 lump sum payment due on or around the effective date (date of full 
execution). Funds are to be expended over the 3-year Period of Performance 
ending June 30, 2023. 
 
 
VII. 
REPORTING 
 
MCDPH will report to AAC at the beginning of the school year and the end of the school 
year: 
 
a. the number of schools who are fully participating in the school stock albuterol 
program,  
b. those schools who are in the process of applying for the school stock inhaler program, 
c. those schools who are contemplating the school stock inhaler program and 
d. the record of expenditures from the grant funding, including inhalers, spacers and the 
administrative fee.

Page 3 
 
  
 
VIII. 
EFFECTIVE DATE AND SIGNATURE 
 
This MOA shall be effective upon full execution. Parties indicate agreement with this MOA 
by signatures below. 
 
 
 
IN WITNESS WHEREOF, the parties agree to the terms indicated herein: 
 
 
FOR AND ON BEHALF OF   
 
FOR AND ON BEHALF OF 
MARICOPA COUNTY 
 
 
ARIZONA ASTHMA COALITION  
 
 
 
_____________________________ 
 
_____________________________ 
 
Clint Hickman  
 
Date 
 
Name  
 
 
Date 
 
Chairman, Board of Supervisors 
 
 
 
ATTEST: 
 
 
_______________________________  
_____________________________ 
 
Office of the Clerk of the Board                         Date  
 
 
 
 
 
APPROVED AS TO FORM  
 
 
 
             ______________________________                ____________________________ 
            Attorney for Maricopa County                            Date

Ex A